Back to Search
FREDERICK FOSS, MD
MD
Trauma Surgery Physician
NPI: 1528041134IndividualAccepts Medicare
Specialties, Licenses & Credentials
Trauma Surgery PhysicianPrimary
Surgery — Trauma Surgery
Code: 2086S0127X
41615(MN)
CMS Specialties
PrimaryGENERAL SURGERY
Education
UNIVERSITY OF NEVADA SCHOOL OF MEDICINE
Class of 1981
Research & Publications (20)
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.
PMID 19632123·Bioorg Med Chem·2009
7-preclinical
In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity.
PMID 18298092·Chem Res Toxicol·2008
8-other
Follicular shuttling of marginal zone B cells facilitates antigen transport.
PMID 18037889·Nat Immunol·2008
7-preclinical
Artificial enzymes with thiazolium and imidazolium coenzyme mimics.
PMID 18763766·J Am Chem Soc·2008
8-other
Oxidation potentials correlate with conductivities of aromatic molecular wires.
PMID 17887757·J Am Chem Soc·2007
8-other
Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma.
PMID 18021473·Clin Lymphoma Myeloma·2007
5-case
The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase.
PMID 17894894·BMC Cancer·2007
4-observational
Mechanisms of trovafloxacin hepatotoxicity: studies of a model cyclopropylamine-containing system.
PMID 17976985·Bioorg Med Chem Lett·2007
8-other
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.
PMID 17113298·Bioorg Med Chem·2007
7-preclinical
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
PMID 17577020·J Clin Oncol·2007
3-trial
Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome.
PMID 17367611·J Am Acad Dermatol·2007
3-trial
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
PMID 17275192·Cancer Treat Rev·2007
6-review
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.
PMID 17943599·Leuk Lymphoma·2007
3-trial
The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
PMID 16549113·Semin Hematol·2006
6-review
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
PMID 17052486·J Am Acad Dermatol·2006
3-trial
Biologic correlates of response and survival in patients with cutaneous T-cell lymphoma treated with denileukin diftitox.
PMID 17229335·Clin Lymphoma Myeloma·2006
3-trial
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
PMID 17940627·Yale J Biol Med·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1015 MARSH ST
MANKATO, MN 56001 - Phone
- (507) 389-4700
Quick Facts
- NPI
- 1528041134
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile